SubsidieMeestersRebuilding Joint Surface to Prevent Pain and Immobility
Askel's COPLA® implant promotes cartilage regeneration and quick rehabilitation to prevent osteoarthritis, aiming to establish a gold standard for pain-free joint movement and improved quality of life.
Projectdetails
Introduction
A healthy layer of articular cartilage at the end of bones in joints is essential for painless movement. When cartilage is damaged, it has minimal innate regenerative properties and there is no effective medical cure.
Impact of Cartilage Damage
Cartilage damage seriously reduces quality of life and has a severe economic impact since loss of cartilage leads to osteoarthritis (OA) that causes hundreds of billions of Euros in healthcare and related costs annually.
Challenges in Cartilage Restoration
Many attempts have been made to restore joint surface cartilage, but the tissue has shown to be extremely difficult to rebuild.
Innovative Solution
Askel has developed a unique way to rebuild joint surfaces for pain-free movement. COPLA® is a biodegradable implant that creates a weight-adaptive microenvironment in the damaged site, enabling quick rehabilitation and cartilage regeneration to prevent OA.
Future Outlook
COPLA® will become the Gold Standard for early cartilage repair with rapid recovery and long-term results, ensuring pain-free movement, high quality of life, and prevention of OA.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.499.000 |
| Totale projectbegroting | € 3.570.000 |
Tijdlijn
| Startdatum | 1-1-2022 |
| Einddatum | 30-6-2024 |
| Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- ASKEL HEALTHCARE OYpenvoerder
Land(en)
Geen landeninformatie beschikbaar
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Articular Cartilage Treatment with Injectable hydrogel is Valuable and long-term EffectiveHy2Care develops a regenerative injectable hydrogel for cartilage repair, promoting natural healing and long-lasting joint health while preventing osteoarthritis. | EIC Accelerator | € 2.500.000 | 2022 | Details |
First in class lateral meniscus prothesis to relieve pain and restore mobility for KOA patientsATRO Medical's Trammpolin is a minimally invasive knee prosthesis designed to relieve pain and restore mobility in severe KOA patients, aiming for market entry in 2026 with a focus on health economics for reimbursement. | EIC Accelerator | € 2.499.402 | 2023 | Details |
A breakthrough active immunotherapy for the treatment of osteoarthritisPeptinov aims to halt osteoarthritis progression through a cost-effective immunotherapy that neutralizes IL-6, with promising Phase I results leading to a Phase II trial for out-licensing readiness. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Next-generation surgical robotics to set a new standard of care in orthopaedic surgeryGanymed is developing an innovative surgical robot that enhances precision and safety in joint-replacement procedures through computer vision and data-driven insights for orthopaedic surgery. | EIC Accelerator | € 2.485.995 | 2022 | Details |
Articular Cartilage Treatment with Injectable hydrogel is Valuable and long-term Effective
Hy2Care develops a regenerative injectable hydrogel for cartilage repair, promoting natural healing and long-lasting joint health while preventing osteoarthritis.
First in class lateral meniscus prothesis to relieve pain and restore mobility for KOA patients
ATRO Medical's Trammpolin is a minimally invasive knee prosthesis designed to relieve pain and restore mobility in severe KOA patients, aiming for market entry in 2026 with a focus on health economics for reimbursement.
A breakthrough active immunotherapy for the treatment of osteoarthritis
Peptinov aims to halt osteoarthritis progression through a cost-effective immunotherapy that neutralizes IL-6, with promising Phase I results leading to a Phase II trial for out-licensing readiness.
Next-generation surgical robotics to set a new standard of care in orthopaedic surgery
Ganymed is developing an innovative surgical robot that enhances precision and safety in joint-replacement procedures through computer vision and data-driven insights for orthopaedic surgery.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Restoring the structural collagen network in the regeneration of cartilageRe-COLL aims to develop durable implants for damaged joints by engineering anisotropic collagen networks through biofabrication and in vitro models, enhancing tissue regeneration and stability. | ERC Advanced... | € 2.500.000 | 2024 | Details |
INTELLECTUALSDit project ontwikkelt een innovatief kraakbeen-op-een-chip model voor gepersonaliseerde behandelingen van osteoartritis. | 1.1 - Het ve... | € 479.529 | 2024 | Details |
SyCap MechanoAvalanche Medical ontwikkelt een duurzaam kunststof implantaat voor kraakbeendefecten in de knie, gericht op middelbare leeftijd patiënten. | Mkb-innovati... | € 20.000 | 2022 | Details |
Regulation of Articular Cartilage Zonal Emergence: Harnessing Developmental Pathways to Enhance RegenerationReZone aims to uncover the mechanisms of zonal emergence in articular cartilage using a goat model to enhance regeneration and improve treatment for cartilage injuries. | ERC Consolid... | € 2.265.746 | 2024 | Details |
Development of a Complete Triple Action Injectable Treatment for OsteoarthritisRelevium Ltd aims to validate and commercialize Hydrobloc, a unique therapy that regenerates cartilage, alleviates pain, and improves joint function in osteoarthritis patients. | EIC Transition | € 2.398.115 | 2022 | Details |
Restoring the structural collagen network in the regeneration of cartilage
Re-COLL aims to develop durable implants for damaged joints by engineering anisotropic collagen networks through biofabrication and in vitro models, enhancing tissue regeneration and stability.
INTELLECTUALS
Dit project ontwikkelt een innovatief kraakbeen-op-een-chip model voor gepersonaliseerde behandelingen van osteoartritis.
SyCap Mechano
Avalanche Medical ontwikkelt een duurzaam kunststof implantaat voor kraakbeendefecten in de knie, gericht op middelbare leeftijd patiënten.
Regulation of Articular Cartilage Zonal Emergence: Harnessing Developmental Pathways to Enhance Regeneration
ReZone aims to uncover the mechanisms of zonal emergence in articular cartilage using a goat model to enhance regeneration and improve treatment for cartilage injuries.
Development of a Complete Triple Action Injectable Treatment for Osteoarthritis
Relevium Ltd aims to validate and commercialize Hydrobloc, a unique therapy that regenerates cartilage, alleviates pain, and improves joint function in osteoarthritis patients.